INTEGRIS BAPTIST MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $3.5M
- Transactions
- 698
- Companies
- 40
- Average per transaction
- $4,978
Who reported the payments
| Merck | $1,264,998 |
| United Therapeutics Corporation | $701,206 |
| Abbott | $626,764 |
| Incyte Corporation | $144,997 |
| Angiodynamics, Inc. | $91,000 |
| Intercept Pharmaceuticals, Inc. | $84,198 |
| Stryker | $80,291 |
| AbbVie | $78,025 |
| Janssen Research & Development, LLC | $74,920 |
| Exelixis Inc. | $60,501 |
| Actelion Pharmaceuticals, Ltd | $41,490 |
| CSL Behring | $37,571 |
| Acell, Inc. | $37,544 |
| M.a. Med Alliance S.A. | $23,360 |
| Astrazeneca UK Limited | $15,288 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | $10,450 |
| Morphosys AG | $10,225 |
| Canon Medical Systems USA, Inc. | $9,000 |
| Vifor (international) Ltd. | $7,417 |
| Bristol Myers Squibb | $6,485 |
| Philips North America LLC | $6,260 |
| Aesculap, Inc. | $6,233 |
| Smith+Nephew | $5,938 |
| Intercept Pharma Europe Ltd. | $5,358 |
| Amgen | $5,230 |
| Bayer | $5,000 |
| Medtronic | $4,450 |
| Johnson & Johnson | $3,987 |
| Genentech, Inc. | $3,329 |
| Merge Healthcare Incorporated | $2,707 |
| Mallinckrodt Enterprises LLC | $2,523 |
| Medline Industries LP | $2,500 |
| Shire North American Group Inc | $2,493 |
| Morphosys, US Inc. | $2,000 |
| E.r. Squibb & Sons, L.L.C. | $1,888 |
| Organogenesis Inc. | $1,505 |
| Biogen | $1,245 |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,195 |
| BD | $1,182 |
| ZOLL Circulation Inc | $1,044 |